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INTERESTING IMAGE18F-FDG PET/CT of Papillary Carcinoma in a
Lateral Thyroglossal Duct CystChristos Sachpekidis, MD,* Matthias S. Dettmer, MD,† Sabine Weidner, MD,*
Roland Giger, MD,‡ and Jan Wartenberg, MD*Abstract: A 69-year-old man presented with bulging of the right oropha-
ryngeal wall, which revealed cytopathologically malignant cells. The man
underwent MRI and 18F-FDG PET/CT, which demonstrated a cystic para-
pharyngeal lesion with an 18F-FDG–avid soft tissue component and right
cervical lymph node. The patient was operated on and showed thyroid can-
cer in normal thyroid tissue, compatible with a papillary thyroid carcinoma
in a lateral thyroglossal duct cyst and 2 ipsilateral lymph node metastases.
Despite its rarity, papillary thyroid carcinoma in a thyroglossal duct cyst
should be kept as one of the differential diagnoses in patients presenting
with parapharyngeal cystic lesion.
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FIGURE 1. Transaxial, contrast-enhanced CT (A) showing a parapharyngeal, cystic lesion with a partially calcified solid
component bulging to the midline. 18F-FDG PET/CT (B) demonstrated moderate tracer uptake in the solid component of
the cystic mass (arrow). The differential diagnosis of a parapharyngeal space lesion includes salivary gland tumors, with
pleomorphic adenomas being the most common neurogenic tumors, among which paragangliomas are the most frequent
cystic lymphangioma (cystic hygroma), branchial cleft cyst, and infectious or inflammatory lesions. Metastatic disease is a rare
diagnosis for a parapharyngeal space tumor.1,2
FIGURE 2. Coronal fused PET/MRI (A) demonstrated the thyroglossal duct cyst (TGDC) as a cystic mass with an 18F-FDG–avid
soft tissue component (arrow), as well as 18F-FDG uptake in an ipsilateral lymph node metastasis (asterisk). The cystic
component of the lesion showed hyperintense signal in the T2-weighted image (B) and hypointense signal in the T1-weighted
image (C). Thyroglossal duct cyst is found in 7% of the population, consisting the most common congenital neck anomaly.3
The majority of TGDCs are located in the midline adjacent to the hyoid bone.4,5 Nevertheless, because of variable branching
patterns of TGDC, less common sites, such as the one presented here, have been reported.4,6 In approximately only 1% of all
TGDCs, thyroid carcinoma may develop.7 Despite the rarity of the diagnosis, the contribution of 18F-FDG PET/CT to the
evaluation of papillary thyroid carcinoma (PTC) arising in TDGC has been demonstrated.8,9 Moreover, other rare cases of
lateral ectopic thyroid tissue revealed by nuclear medicine techniques have been documented.10 The patient underwent
resection of the parapharyngeal mass and ipsilateral selective neck dissection with frozen section revealing PTC, followed by
total thyroidectomy and adjuvant radioiodine therapy. Pathology revealed a PTC, hobnail variant in nonmalignant thyroid
parenchyma compatible with a thyroid cancer in a lateral TGDC, as well as 2 lymph node metastases and an incidental
microcarcinoma in the left thyroid gland. Although the scenario of metastatic spread from this occult contralateral thyroid
carcinoma cannot be formally excluded, 2 reasonsmake this hypothesis highly unlikely: first, incidental papillarymicrocarcinomas
are extremely indolent lesions, and second, the PTC found in the TGDC demonstrates a rare aggressive PTC subtype, which is
well in line with the observed lymph node metastases.
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FIGURE 3. The posttherapy scan after adjuvant radioiodine 131I therapy with transaxial (A), sagittal (B), and coronal
(C) SPECT/CT, as well as planar scan (D), showed a focal uptake in the pyramidal lobe likely corresponding to a remnant of a
thyroglossal duct. No other site of pathological tracer accumulation was depicted. Serum thyroglobulin (Tg) after operation
but before radioiodine therapy was 0.42 ng/mL, whereas the anti-Tg antibody test was negative. Serum Tg was undetectable
3 months after radioiodine therapy (value <0.17 ng/mL).
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FIGURE 4. Resected parapharyngeal mass showing parts of
the ruptured cystic wall (arrow) and the solid component
(asterisk).
Sachpekidis et al Clinical Nuclear Medicine • Volume 42, Number 8, August 2017FIGURE 5. Histology shows PTC hobnail variant next to classic PTC areas (not shown) in this TGDC. The tumor shows
micropapillary architecture (yellow arrow) and loss of cellular polarity (blue arrow). The dissociation of tumor cells from the
stroma can be easily appreciated (green arrow; hematoxylin-eosin stain, original magnification 200).
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